Fasting triglycerides as a predictor of incident diabetes, insulin resistance and β-cell function in a Canadian First Nation

References

• International Diabetes Federation. IDF diabetes atlas. 7th ed. 2015. [ cited 2017 Mar 13]. Available from: file:///C:/Users/umriedin/Downloads/IDF_Atlas%202015_UK.pdf
   Google Scholar
• Mansuri S, Hanley AJ. Diabetes among indigenous canadians. In diabetes mellitus in developing countries and underserved communities. Memphis, Tennessee: Springer International Publishing; 2017. p. 1–8.
   Google Scholar
• Riediger ND, Lukianchuk V, Bruce SG. Incident diabetes, hypertension, and dyslipidemia in a Manitoba first nation. Int J Circumpolar Health. 2015;74:27712.
   Google Scholar
• Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care. 2008;31:1837–1841.
   Google Scholar
• Riediger ND, Lix LM, Lukianchuk V, et al. Trends in diabetes and cardiometabolic conditions in a Canadian first nation community. Prev Chronic Dis. 2014;11(E198):1–8.
   Google Scholar
• Zacharias JM, Young TK, Riediger ND, et al. Prevalence, risk factors and awareness of albuminuria on a Canadian first nation: a community-based screening study. BMC Public Health. 2012;12:290.
   Google Scholar
• Canadian Diabetes Association. An economic tsunami: the cost of diabetes in Canada. 2009 Dec. [ cited 2017 Mar 13]. Available from: http://www.diabetes.ca/CDA/media/documents/publications-and-newsletters/advocacy-reports/economic-tsunami-cost-of-diabetes-in-canada-english.pdf
   Google Scholar
• Dotevall A, Johansson S, Wilhelmsen L, et al. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med. 2004;21(6):615–622.
   Google Scholar
• He S, Wang S, Chen X, et al. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism. 2012;61(1):30–36.
   Google Scholar
• Hjellvik V, Sakshaug S, Strøm H. Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin Epidemiol. 2012;4:213–224.
   Google Scholar
• Joseph J, Svartberg J, Njølstad I, et al. Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study. Scand J Public Health. 2010;38(7):768–775.
   Google Scholar
• Ginsberg HN, Zhang Y-L, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36(3):232–240.
   Google Scholar
• Mclaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(Ldl):802–809.
   Google Scholar
• Perry IJ, Wannamethee SG, Walker MK, et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ. 1995;310(6979):560–564. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2548938&tool=pmcentrez&rendertype=abstract
   Google Scholar
• Olafsdottir E, Aspelund T, Sigurdsson G, et al. Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik). Eur J Epidemiol. 2009;24(6):307–314.
   Google Scholar
• Ley SH, Harris SB, Connelly P, et al. Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012;12:821–825.
   Google Scholar
• Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to aboriginal people? Med J Aust. 2005;182:66–69.
   Google Scholar
• Mann DM, Bertoni AG, Shimbo D, et al. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort. Am J Epidemo. 2010;171:980–988.
   Google Scholar
• Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
   Google Scholar
• Canadian Society for Exercise Physiology. Canadian physical activity, fitness and lifestyle approach. 3rd ed. Ottawa, Ontario (CA): Canadian Society for Exercise Physiology; 2003.
   Google Scholar
• Alberti K, Eckel R, Grundy S, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645.
   Google Scholar
• St-Pierre J, Lemieux I, Perron P, et al. Relation of the “Hypertriglyceridemic waist” phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J of Cardiology. 2007;99(3):369–373.
   Google Scholar
• Clinical guidelines task force. Global guideline for type 2 diabetes. Brussels (Belgium): International Diabetes Federation; 2012.
   Google Scholar
• Matthews DR, Hosker JR, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
   Google Scholar
• Zafrir B, Jain M. Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovasc Drugs Ther. 2014;28(4):361–377.
   Google Scholar
• Flory J, Ellenberg S, Szapary P. Antidiabetic action of bezafibrate in a large observational database. Diabetes Care. 2009;32(4):547–551.
   Google Scholar
• Moro E, Gallina P, Pais M, et al. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes. Metabolism. 2003;52(5):616–619.
   Google Scholar
• Kim-Dorner S, Deuster P, Zeno S, et al. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism. 2010;59(2):299–304.
   Google Scholar
• Koller KR, Metzger JS, Jolly SE, et al. Cardiometabolic correlates of low type 2 diabetes incidence in Western Alaska Native people - the WATCH study. Diabetes Res Clin Pract. 2015;108(3):423–431.
   Google Scholar
• Razak F, Anand S, Vuksan V, et al. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond). 2005;29(6):656–667.
   Google Scholar
• Egeland G, Cao Z, Young T. Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: the international polar year inuit health survey for adults 2007-2008. CMAJ. 2011;183(9):E553–8.
   Google Scholar
• Hopkins S, Austin M, Metzger J, et al. Sex differences in obesity prevalence and cardiometabolic risk factors among Western Alaska Native people. Nutr Metab Cardiovasc Dis. 2015;25(3):312–318.
   Google Scholar
• Green C, Blanchard JF, Young TK, et al. The epidemiology of diabetes in the Manitoba-registered first nation population: current patterns and comparative trends. Diabetes Care. 2003;26(7):1993–1998.
   Google Scholar
• Dyck R, Osgood N, Lin TH, et al. Epidemiology of diabetes mellitus among first nations and non-first nations adults. Can Med Assoc J. 2010;182:249–256.
   Google Scholar
• Johnson JA, Vermeulen SU, Toth E, et al. Increasing incidence and prevalence of diabetes among the status aboriginal population in urban and rural Alberta, 1995-2006. Can J Pub Health. 2009;100:231–236.
   Google Scholar